Abraxis BioScience will purchase Pfizer’s Cruce Davila manufacturing facility in Barceloneta, Puerto Rico. This 56-acre site consists of a 172,000-sq.-ft. validated manufacturing plant with capabilities of producing EU and US compliant injectable pharmaceuticals, as well as protein based biologics and metered dosed inhalers. In addition, the acquisition includes a state-of-the-art, computer-controlled 90,000-sq.-ft. API manufacturing plant, and two support facilities with quality assurance...